Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cynthia G Whitney, MD"'
Autor:
Zachary J Madewell, PhD, Cynthia G Whitney, MD, Nega Assefa, PhD, Quique Bassat, MD, Shams El Arifeen, DrPH, Emily S Gurley, PhD, Amara Jambai, MD, Karen L Kotloff, MD, Shabir A Madhi, PhD, Inacio Mandomando, PhD, Ikechukwu U Ogbuanu, MD, Dickens Onyango, MD, J Anthony G Scott, FMedSci, Samba O Sow, MD, Beth A Tippett Barr, DrPH, Dianna M Blau, PhD
Publikováno v:
The Lancet Global Health, Vol 10, Iss , Pp S8- (2022)
Background: Globally, mortality in children younger than 5 years has been decreasing over the past few decades, but high under-5 mortality persists across regions of sub-Saharan Africa and southern Asia. Interventions—such as improved quality of cl
Externí odkaz:
https://doaj.org/article/3fd65a9fe5464985bc2dcdd60c2d0dbf
Autor:
Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 7, Pp e989-e998 (2021)
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine se
Externí odkaz:
https://doaj.org/article/3257b2810c1b45db97f356b85595ed14
Autor:
Cheryl Cohen, DrPhD, Claire von Mollendorf, MD, Linda de Gouveia, NDMedTech, Sarona Lengana, MD, Susan Meiring, MD, Vanessa Quan, MD, Arthermon Nguweneza, MSc, David P Moore, MD, Gary Reubenson, MD, Mamokgethi Moshe, MD, Shabir A Madhi, ProfPhD, Brian Eley, ProfMD, Ute Hallbauer, MD, Heather Finlayson, MD, Sheeba Varughese, MD, Katherine L O'Brien, ProfMD, Elizabeth R Zell, MSc, Keith P Klugman, ProfPhD, Cynthia G Whitney, MD, Anne von Gottberg, PhD
Publikováno v:
The Lancet Global Health, Vol 5, Iss 3, Pp e359-e369 (2017)
Summary: Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was designed to include disease-causing serotypes that are important in low-income and middle-income countries. Vaccine effectiveness estimates are scarce in these settings. So
Externí odkaz:
https://doaj.org/article/84a3737168cb4c099c51ecc3aaa357fc